Novavax: Partner Takeda Submits NDA In Japan For Approval Of COVID-19 Vaccine
16/12 06:06
(RTTNews) - Novavax, Inc. (NVAX), a biotechnology company, announced late Wednesday that its the submission of a New Drug Application or NDA in Japan for its COVID-19 vaccine by its partner Takeda Pharmaceutical Co. Ltd. (TKPHF.PK, TAK)....